Clinical Exploration Study of YOLT-203 in the Treatment of Type 1 Primary Hyperoxaluria (PH1)

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 15, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Type 1 Primary Hyperoxaluria

Interventions

DRUG

YOLT-203

The IP is administered intravenously at the predetermined dose.

Trial Locations (1)

RECRUITING

Deparment of Liver Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai

All Listed Sponsors

lead

RenJi Hospital

OTHER